FDAFDA · Food and drugs·Recall number D-0148-2024
Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01
Published December 20, 2023 · Recall initiated: November 22, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- PENICILLAMINE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to 3 wholesale/distributor accounts.
- UPC
- 0370748153017
- Lot
- Lot # M200498, Exp. June 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.